Spigelia anthelmia

Spigelia anthelmia
-------------------

Loganiaceae

---------------

Herb

-----

Pink root

------------

The Od Force of the root is used as one of the components in the preparation of the remedy. As herbal it is poisonous.

This Od Force can be identified as the escorter of the cardioactive principle achieved by doing chemical reaction with human cells. . The biological effect of it is characterized by an expansion development of the heart muscle. It destroys the illicit passage of the cell to cell negatively charged Electromagnetic pathways network that the worms use to rule in the intestine as focus. 

It exerts a powerful withdrawing effect that was acting on the nervous system of the same strongly, especially of narcotic sufferings. It sweeps the chemical tortures exerted upon the nerves and their envelopes. It rescues the human system from the marked elective affinity of the eye, heart and nervous system. Neuralgia of the fifth nerve is one of its subjects. The subjects take the birth from the chemically adapted anaemic, debilitated, rheumatic and scrofulous are fed by this Force to erase the diversions caused in these respect. It bows out the problems originated from the loss of Od Force in the chemical solution of pericarditis.

The work done by the chemicals effective against heart disease, other heart problems, such as heart murmurs of abnormal heart sounds, rheumatic heart disease, angina ( chest pain) and valve disorders, relieved chest pain ( angina pectoralis) extending into chest, arms and throat as well are also cancelled by this Od Force. Chemical dip passages of the rheumatic endocarditis, rheumatic opthalmia and facial neuralgia, eased pain associated with the eyes and teeth including rheumatic fever, inflammatory swellings of the joints and palpitation arising from the mitral and aortic disease are regained similarly in the use of this Od Force.

It calms the excited nerves of special sense in a marked degree. In this activity it withdraws the inflammatory diversions produced in the sclerotic and choroid. It lifts the functionary alteration of special sense in the optic nerve and retina. In the tissues of the eye it cools down the excited inflammation that does rheumatic sclerotitis. It cancels the chemical reactions decidedly acted on the trifacial nerve. It foils the produced prosopalgia which involves the orbit, the zygoma and the superior maxilla, on the nerves of the tongue, also on the portio dura. It cancels the chemically embraced effects on the fibrous and muscular tissues of the eye, heart, and perhaps of the extremities also. It functions to withdraw the focus appeared from the chemically tackled sufferings of the pharynx and posterior nares.

 The high repute of this Od Force as an anti-helminthiasis might lead us to expect a more decided action on the apparatus of digestion. The presence of such decided action explains that it escorts the intestinal apparatus from its modified chemical condition caused in helminthiasis during their development and flourish, to its previous state.

Its efficiency in canceling the chemical diversion of treated cancer and HIV.

To stop damage of heart, dizziness, dizziness, convulsion vision problem its use is easily explainable. Women pregnant or nursing may find its pleasure in it. Diversions caused from the chemically treated head maladies, such as migraines, general headaches, and sinus infections, may also be remedied through the use of this Od Force. It repairs the damage caused by the laxatives and bacteria. It may be included for its activities to withdraw the chemical essay of the treated common cold congestion etc.

It opens the blocks of the ryanodine receptor to withdraw the chemical diversion caused from the reaction caused by the plant as herbal.

This receptor is associated with calcium conductance channel in the sarcoplasmic or endoplasmic reticulum of cells, which when bound to ryanodine, causes the channel to remain in a subconductive state, allowing slow continuing release of calcium ions from the sarcoplasmic reticulum into the cytoplasm. The channels are normally sensitive to calcium ions being ignorance of the inositol triphospate. A second messenger formed from phosphatidylinositol 4,5-bisphosphate;triggers the release of calcium ions from special 

vesicles of the endoplasmicreticulum, has a role in the activation of the neutrophils. Any involvement in disordering the described works is withdrawn by this Od Force.

It will be very worthy to note further that ryanodine receptors (RyRs)   form a class of intracellular calcium channels in various forms of excitable tissue like muscles and neurons. There are three major isoforms of the ryanodine receptor, which are found in different tissues and participate in different signaling pathways involving calcium release from intracellular organelles. The RYR2 ryanodine receptor isoform is the major cellular mediator of calcium-induced calcium release (CICR) in cells.

The cardiac ryanodine receptor (RyR2) is the major calcium (Ca²⁺) release channel on the sarcoplasmic reticulum (SR) in cardiomyocytes. During excitation-contraction, coupling intracellular Ca²⁺ stored in the SR is released via RyR2 to activate muscle contraction. In the heart, excitation-contraction coupling is activated by Ca²⁺ influx via the L-type Ca²⁺ channel that activates RyR2, a process referred to as Ca²⁺-induced Ca²⁺ release. The cardiac muscle RyR2 and its homologue, the skeletal muscle RyR1, are macromolecular complexes that include four ≈565-kDa RyR1 or RyR2, four FKBP12 or FKBP12.6 (12-kDa peptidyl-prolyl isomerases that are required for normal gating of the channels), as well as cAMP-dependent kinase (PKA), phosphatases, and their targeting proteins. One key role for the macromolecular signaling complex is to modulate channel function in response to activation of the sympathetic nervous system (ie, the classic “fight-or-flight” stress response).

There are at least 21 mutations in RyR2 that are linked to stress-induced sudden cardiac death. RyR2 mutations have been associated with 2 forms of sudden cardiac death (SCD): (1) catecholaminergic polymorphic ventricular tachycardia (CPVT) or familial polymorphic ventricular tachycardia (FPVT), and (2) arrhythmogenic right ventricular dysplasia type 2 (ARVD2).

Locations of SCD mutations in human RyR2 compared with MH/CCD regions of RyR1 and known regulatory domains of the channel. Eleven reported SCD-linked RyR2 mutations cluster in three regions homologous to three MH/CCD regions. The location of 3 RyR2 leucine/isoleucine zippers (LZ) that target PP1, PP2A, and PKA to RyR2 as is the FKBP12.6 binding region, and the CaM binding site.

CPVT and FPVT are acronyms for similar, autosomal, dominantly inherited disorders, characterized by adrenergic (exercise or stress)–induced, bidirectional, and polymorphic ventricular tachycardias that cause SCD in the absence of gross structural disease of the myocardium. CPVT of children is with stress-induced ventricular arrhythmias that are predominantly bidirectional ventricular tachycardias, whereas the FPVT patients have predominantly polymorphic ventricular tachycardia.

4 RyR2 missense mutations, 3 of which (S2246L, R2474S, and N4104K) may be sporadic and the rest one (R4497C) may be found with clinically affected mutation carriers. FPVT carrying missense mutations P2328S, Q4201R, and V4653F are also there. There are at least 6 genetically distinct forms of primarily autosomal, dominantly inherited arrhythmogenic right ventricular dysplasia (ARVD) cardiomyopathies, characterized by progressive degeneration of the right ventricular myocardium, arrhythmias, and SCD. ARVD2 is characterized by exercise-induced SCD, to chromosome 1q42-q43. RyR2 mutations in 4 ARVD2, N2386I mutation, and different mutations (R176Q and T2504M), L433P missense mutation are also notable.

 RyR2-linked CPVT/FPVT/ARVD2 mutations are associated with increased adrenergic activity due to sympathetic nervous system stimulation. Thus, the molecular pathophysiology of SCD in patients with CPVT/FPVT/ARVD2 may be analogous to SCD in patients with heart failure.  In failing hearts, a chronic hyperadrenergic state is associated with PKA hyperphosphorylation of RyR2, which depletes the channel of the regulatory subunit FKBP12.6. A diastolic leak of Ca²⁺ due to a hyperactive RyR2 may be one signal that accounts for delayed afterdepolarizations that trigger ventricular tachycardia. Interestingly, 8 of the RyR2 mutations linked to SCD are in the FKBP12.6-binding region of the channel.

The CPVT with RyR2 mutations exhibit earlier onset of stress-induced ventricular tachycardia, compared with CPVT individuals without RyR2 mutations in about 50% of the cases. Moreover, males with RyR2 mutations had a higher risk of syncope (relative risk of 4.2). The care of patients with CPVT tags the chemical uses of the use of prophylactic β-adrenergic receptor blockers in all male children who are carriers of RyR2 mutations. However, ≈30% of the patients with CPVT required an implantable defibrillator.

 RyR2 mutations are linked with the stress-induced SCD in the alterations in structure making the mutant channels hypersensitive to the downstream effectors of the β-adrenergic signaling pathway, namely phosphorylation by PKA. Stress-induced activation of the sympathetic nervous system results in PKA phosphorylation of RyR2 dissociates FKBP12.6 from the channel and increases the Ca²⁺-induced activation of the channel. In failing hearts, RyR2 are PKA hyperphosphorylated such that 3 or 4 of the PKA sites in each channel complex are phosphorylated and the channels are depleted of FKBP12.6, resulting in an SR Ca²⁺ “leak.” It may be that the RyR2 mutations linked to SCD make the channels more sensitive to activation by PKA phosphorylation in such a way that, under particularly stressful conditions, the mutant channels act like the PKA-hyperphosphorylated channels in failing hearts. The resulting SR Ca²⁺ leak could activate inward, depolarizing currents via the Na⁺/Ca²⁺ exchanger, possibly causing delayed afterdepolarizations that are known to trigger fatal ventricular arrhythmias.

RyR2 mutations linked to SCD could alter the PKA phosphorylation modulation of the channel by increasing PKA targeting to the channel or decreasing phosphatase (PP1 and PP2A) targeting to the channel. PKA, PP1, and PP2A are targeted to RyR2 via targeting proteins that bind via leucine/isoleucine zipper motifs in the channel. It is interesting to note that a defect in the leucine/isoleucine zipper-mediated targeting of PKA and PP1 to the potassium channel KCNQ1, linked to exercise-induced SCD in individuals with long-QT syndrome has also be been demonstrated, though none of the SCD-linked RyR2 mutations have been found in sequences that are known to mediate PKA, PP1, or PP2A targeting to RyR2. It is again   notable that individuals with CPVT/FPVT/ARVD2-linked RyR2 mutations only manifest symptoms under conditions of sympathetic nervous system activation.

The CPVT/FPVT/ARVD2 mutations cluster in 3 regions of the channel, corresponding to malignant hyperthermia (MH) and central core disease (CCD) domains in RyR1. MH and CCD are diseases of skeletal muscle, and their mutations may alter the Ca²⁺-dependent regulation of RyR1 generally. Mutant RyR1 channels isolated from MH may reveal an increased sensitivity to activation by Ca²⁺ and a decreased sensitivity to inhibition by Mg²⁺.These alterations in the biophysical properties of the channels could cause an SR Ca²⁺ leak.

In terms of therapeutic approaches for CPVT/FPVT/ARVD2-linked SCD, support for the concept that systemic β-blockers can “protect” the RyR2 channel from the consequences of sympathetic nervous system activation can be derived as systemic β-blockers reversing the PKA hyperphosphorylation of RyR2 in failing hearts and restore the normal structure and function of the channel.

 Individuals with CPVT whose initial symptoms occurred in adulthood are not of just in childhood. Patients with CPVT linked to RyR2 mutations are of predominantly male and developed symptoms earlier in life than does those without RyR2 mutations, who are predominantly female.

Genes other than RyR2 implicates in catecholamine-induced ventricular tachycardia as well. An autosomal recessive form of catecholamine- or exercise-induced polymorphic ventricular tachycardia with mutations in calsequestrin can be carried.

This Od Force has an immense quality to withdraw all the focus as have been narrated here to cause the reverse to escort the affected human system from the den of the above to its previous state.